BioBreakthroughs
BioBreakthroughs

BioBreakthroughs

      |      

Prenumeranter

   Senaste videorna

#17 - Raquel Izumi, President & COO at Vincerx Pharma Inc
15:58
#15 – Paul Billings, CEO And Director Of Biological Dynamics
15:33
#14 – Simon Arkell, CEO and Co-Founder of Synthetica Bio
15:10
#12 - Pascal Touchon, President and CEO at Atara Biotherapeutics
17:09
#11 – Jason Bock, CEO At CTMC
13:25
#10 – Pete O’Heeron, Chairman/CEO/Founder, FibroBiologics
12:17
#9 - Nolan Townsend, CEO of LEXEO Therapeutics
18:48
#8 - Sandra von Meier, Head of Business Development at Debiopharm
16:15
#7 - David Esposito, President and CEO of ONL Therapeutics
15:29
#6 - Richard Brandon, Chief Scientific Officer at Immunexpress
11:13
#4 - Joel Morse, CEO at Curavit Clinical Research
15:23
#3 - Chris Bahl, Co-Founder, President & Chief Scientific Officer at AI Proteins
15:23
Visa mer